225 related articles for article (PubMed ID: 31014561)
1. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
[TBL] [Abstract][Full Text] [Related]
2. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
[TBL] [Abstract][Full Text] [Related]
3. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
[TBL] [Abstract][Full Text] [Related]
4. An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Sert A; Yazar A; Odabas D; Bilgin H
Pediatr Pulmonol; 2010 Jul; 45(7):734-6. PubMed ID: 20575093
[TBL] [Abstract][Full Text] [Related]
5. A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.
Hyle EP; Shu B; Lindstrom S; Klimov A; Hancock K; Ferraro MJ; Traum AZ; Michelow IC
Pediatr Transplant; 2012 Aug; 16(5):E158-61. PubMed ID: 21429059
[TBL] [Abstract][Full Text] [Related]
6. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
7. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
8. Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.
Medeiros R; Rameix-Welti MA; Lorin V; Ribaud P; Manuguerra JC; Socie G; Scieux C; Naffakh N; van der Werf S
Antivir Ther; 2007; 12(4):571-6. PubMed ID: 17668567
[TBL] [Abstract][Full Text] [Related]
9. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
[TBL] [Abstract][Full Text] [Related]
10. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient.
Shetty AK; Ross GA; Pranikoff T; Gubareva LV; Sechrist C; Guirand DM; Abramson J; Lin JJ
Pediatr Transplant; 2012 Aug; 16(5):E153-7. PubMed ID: 22764830
[TBL] [Abstract][Full Text] [Related]
12. Swine flu outbreak. What role for antiviral drugs?
Couzin-Frankel J
Science; 2009 May; 324(5928):705. PubMed ID: 19423784
[No Abstract] [Full Text] [Related]
13. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
[TBL] [Abstract][Full Text] [Related]
14. [Current anti-influenza virus chemotherapy].
Yoshioka D; Tokimatsu I; Ishii H; Kadota J
Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
[TBL] [Abstract][Full Text] [Related]
15. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
16. Antiviral drugs for influenza 2013-2014.
Med Lett Drugs Ther; 2014 Jan; 56(1434):6-8. PubMed ID: 24457560
[No Abstract] [Full Text] [Related]
17. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
[TBL] [Abstract][Full Text] [Related]
18. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
Dulek DE; Williams JV; Creech CB; Schulert AK; Frangoul HA; Domm J; Denison MR; Chappell JD
Clin Infect Dis; 2010 Jun; 50(11):1493-6. PubMed ID: 20415572
[TBL] [Abstract][Full Text] [Related]
19. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
